Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Deceased-donor characteristics and the survival benefit of kidney transplantation.

Merion RM, Ashby VB, Wolfe RA, Distant DA, Hulbert-Shearon TE, Metzger RA, Ojo AO, Port FK.

JAMA. 2005 Dec 7;294(21):2726-33.

PMID:
16333008
2.

Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium.

Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair JH, Fisher RA, Freise CE, Kam I, Pruett TL, Everhart JE, Hulbert-Shearon TE, Gillespie BW, Emond JC; A2ALL Study Group.

Ann Surg. 2005 Sep;242(3):314-23, discussion 323-5.

3.

Analytical approaches for transplant research, 2004.

Schaubel DE, Dykstra DM, Murray S, Ashby VB, McCullough KP, Dickinson DM, Hulbert-Shearon TE, Webb RL, Wolfe RA.

Am J Transplant. 2005 Apr;5(4 Pt 2):950-7.

4.

Thoracic organ transplantation in the United States, 1994-2003.

Barr ML, Bourge RC, Orens JB, McCurry KR, Ring WS, Hulbert-Shearon TE, Merion RM.

Am J Transplant. 2005 Apr;5(4 Pt 2):934-49.

5.

Improvements in dialysis patient mortality are associated with improvements in urea reduction ratio and hematocrit, 1999 to 2002.

Wolfe RA, Hulbert-Shearon TE, Ashby VB, Mahadevan S, Port FK.

Am J Kidney Dis. 2005 Jan;45(1):127-35.

PMID:
15696452
6.

High dialysis dose is associated with lower mortality among women but not among men.

Port FK, Wolfe RA, Hulbert-Shearon TE, McCullough KP, Ashby VB, Held PJ.

Am J Kidney Dis. 2004 Jun;43(6):1014-23.

PMID:
15168381
7.

Analytical approaches for transplant research.

Wolfe RA, Schaubel DE, Webb RL, Dickinson DM, Ashby VB, Dykstra DM, Hulbert-Shearon TE, McCullough KP.

Am J Transplant. 2004;4 Suppl 9:106-13. Review.

8.

Pediatric transplantation.

Magee JC, Bucuvalas JC, Farmer DG, Harmon WE, Hulbert-Shearon TE, Mendeloff EN.

Am J Transplant. 2004;4 Suppl 9:54-71. Review.

9.

Influence of graft type on outcomes after pediatric liver transplantation.

Roberts JP, Hulbert-Shearon TE, Merion RM, Wolfe RA, Port FK.

Am J Transplant. 2004 Mar;4(3):373-7.

10.

Analytical approaches for transplant research.

Wolfe RA, Webb RL, Dickinson DM, Ashby VB, Dykstra DM, Hulbert-Shearon TE, McCullough KP.

Am J Transplant. 2003;3 Suppl 4:103-13. Review. No abstract available.

11.

Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease.

Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG.

J Am Soc Nephrol. 2003 Feb;14(2):415-24.

12.

Lack of correlation between facility-based standardized rates of transplantation and mortality.

Okechukwu CN, Hulbert-Shearon TE, Wiggins RC, Wolfe RA, Port FK.

Am J Kidney Dis. 2002 Aug;40(2):381-4.

PMID:
12148112
13.

Tailoring the initial vascular access for dialysis patients.

Konner K, Hulbert-Shearon TE, Roys EC, Port FK.

Kidney Int. 2002 Jul;62(1):329-38.

14.

Type of vascular access and mortality in U.S. hemodialysis patients.

Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK.

Kidney Int. 2001 Oct;60(4):1443-51.

15.

Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients.

Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK.

J Am Soc Nephrol. 2001 Oct;12(10):2131-8.

16.

Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the usrds dialysis morbidity and mortality study.

Port FK, Wolfe RA, Hulbert-Shearon TE, Daugirdas JT, Agodoa LY, Jones C, Orzol SM, Held PJ.

Am J Kidney Dis. 2001 Feb;37(2):276-86.

PMID:
11157367
17.

Predictors of loss of residual renal function among new dialysis patients.

Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, Hulbert-Shearon T, Jones CA, Bloembergen WE.

J Am Soc Nephrol. 2000 Mar;11(3):556-64.

18.

Prescription of twice-weekly hemodialysis in the USA.

Hanson JA, Hulbert-Shearon TE, Ojo AO, Port FK, Wolfe RA, Agodoa LY, Daugirdas JT.

Am J Nephrol. 1999;19(6):625-33.

PMID:
10592355
19.

Introduction to the excerpts from the United States Renal Data System 1999 Annual Data Report.

Wolfe RA, Port FK, Webb RL, Bloembergen WE, Hirth R, Young EW, Ojo AO, Strawderman RL, Parekh R, Stack A, Tedeschi PJ, Hulbert-Shearon T, Ashby VB, Callard S, Hanson J, Jain A, Meyers-Purkiss A, Roys E, Brown P, Wheeler JR, Jones CA, Greer JW, Agodoa LY.

Am J Kidney Dis. 1999 Aug;34(2 Suppl 1):S1-3. No abstract available.

PMID:
10430996
20.

Survival advantage in Asian American end-stage renal disease patients.

Wong JS, Port FK, Hulbert-Shearon TE, Carroll CE, Wolfe RA, Agodoa LY, Daugirdas JT.

Kidney Int. 1999 Jun;55(6):2515-23.

21.

Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients.

Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE, Golper TA, Agodoa LY, Young EW.

Am J Kidney Dis. 1999 Mar;33(3):507-17.

PMID:
10070915
22.

A critical examination of trends in outcomes over the last decade.

Wolfe RA, Held PJ, Hulbert-Shearon TE, Agodoa LY, Port FK.

Am J Kidney Dis. 1998 Dec;32(6 Suppl 4):S9-15.

PMID:
9892361
23.

Noncompliance in hemodialysis: predictors and survival analysis.

Leggat JE Jr, Orzol SM, Hulbert-Shearon TE, Golper TA, Jones CA, Held PJ, Port FK.

Am J Kidney Dis. 1998 Jul;32(1):139-45.

PMID:
9669435
24.

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

Block GA, Hulbert-Shearon TE, Levin NW, Port FK.

Am J Kidney Dis. 1998 Apr;31(4):607-17.

PMID:
9531176
25.

An analysis of risk factors for withdrawal from dialysis before death.

Leggat JE Jr, Bloembergen WE, Levine G, Hulbert-Shearon TE, Port FK.

J Am Soc Nephrol. 1997 Nov;8(11):1755-63.

26.

Lod score curves for phase-unknown matings.

Hulbert-Shearon T, Boehnke M, Lange K.

Hum Hered. 1996 Jan-Feb;46(1):55-7.

PMID:
8825464

Supplemental Content

Loading ...
Support Center